Impact of antifibrotic therapy on mortality and acute exacerbation in idiopathic pulmonary fibrosis: a systematic review and meta-analysis

T Petnak, P Lertjitbanjong, C Thongprayoon, T Moua - Chest, 2021 - Elsevier
Background Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung
disease associated with significant morbidity and mortality. Nintedanib and pirfenidone are …

[HTML][HTML] Acute exacerbation in interstitial lung disease

EH Alhamad, JG Cal, NN Alrajhi… - Annals of Thoracic …, 2021 - journals.lww.com
BACKGROUND: Information regarding acute exacerbation (AE) in patients with interstitial
lung disease (ILD) is limited. OBJECTIVES: The objective of the study was to elucidate the …

[HTML][HTML] Clinical characteristics and outcomes in patients with primary Sjogren's syndrome-associated interstitial lung disease

EH Alhamad, JG Cal, NN Alrajhi… - Annals of Thoracic …, 2021 - journals.lww.com
BACKGROUND: Diagnosing primary Sjogren's syndrome (pSS)-associated interstitial lung
disease (ILD) is complex and can be very challenging. In addition, information about the …

Effects of oxygen supplementation in autonomic nervous system function during exercise in patients with idiopathic pulmonary fibrosis and exertional desaturation

AK Boutou, K Dipla… - The Clinical …, 2021 - Wiley Online Library
Introduction Patients with idiopathic pulmonary fibrosis (IPF) have reduced exercise capacity
and often present exertional dyspnea and desaturation. The role of autonomic nervous …

Idiopathic Pulmonary Fibrosis-Improving Supportive Care Pathway

T Fowora - 2021 - search.proquest.com
It is important to have patient-reported outcome measures (PROM) to assess essential
variables that negatively impacted the health-related quality of life for patients. The project …